Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 205-214, Vol. 75, No. 1
Collaborative Anti-Viral Research Group,
Institute of Molecular and Cell Biology, Singapore
117609,1 and Department of
Medicine, National University Hospital, Singapore
119074,3 Singapore, and The Molecular
Sciences Institute Inc., Berkeley, California
947042
Received 17 July 2000/Accepted 4 October 2000
Interaction between viral proteins is necessary for viral
replication and viral particle assembly. We used the yeast two-hybrid assay to identify interactions among all the mature proteins of the
hepatitis C virus. The interaction between NS3 and
NS3 was one of the strongest viral protein-protein interactions
detected. The minimal region required for this interaction was
mapped to a specific subdomain of 174 amino acids in the N
terminus of the helicase region. Random mutations in the minimal
region were generated by PCR, and mutants that failed to interact
with a wild-type minimal fragment were isolated using the yeast
two-hybrid assay as a screen. Three of these mutations resulted
in a reduction or a loss of interaction between helicases.
Analytical gel filtration showed that in the presence of
an oligonucleotide, wild-type helicases form dimers whereas
the mutants remain mostly monomeric. All three mutants were partially or almost inactive when assayed for
helicase activity in vitro. Mixing a mutant helicase (Y267S) with
wild-type helicase did not dramatically affect helicase activity. These data indicate that dimerization of the helicase is important for helicase activity. The mutations that reduce
self-association of the helicase may define the key residues involved
in NS3-NS3 dimerization.
Hepatitis C virus (HCV) is a
positive-strand RNA virus that belongs to the family
Flaviviridae. It is one of the major causes of liver
disease, affecting 1 to 2% of the population in most developed
countries. Seventy-five percent of HCV infections are chronic; up to
20% of these develop into liver cirrhosis, and another 1 to 5% of
cases lead to hepatocellular carcinoma. To date, treatment of this
infection using interferon and ribavirin has not been sufficiently
effective. The discovery of new drugs to counter HCV-associated liver
conditions has been hampered by the lack of reliable cell culture and
inexpensive animal model systems.
The HCV positive-strand RNA genome is translated in the host cell into
a large polypeptide of about 3,010 amino acids (aa), which is cleaved
into 10 individual protein products (6, 20). The
three structural proteins Many antiviral drug screens have been targeted at NS3, the
nonstructural protein that has protease, nucleoside
triphosphatase (NTPase), and helicase activities. The structures
of both protease and helicase domains of NS3 have been elucidated by
X-ray crystallography (5, 12, 13, 19). The NS3 helicase
belongs to the DEXH family of helicases, with conserved motifs
essential for NTP-binding, NTPase, helicase
(G207SGKST, D290ECH,
T322AT), and RNA-binding
(Q460RRGRTGRGRGG) activities. It has been
suggested to form a dimer, with a cleft between the components
of the dimer through which a single-stranded nucleotide can pass
as the helicase unwinds the RNA (5). Other helicases are
also known to form and function as dimers or oligomers (1,
3). Dimerization or oligomerization of NS3 helicase has been
implicated to be necessary for optimal helicase activity
(15), although other studies report that the HCV helicase
is monomeric in solution (25) and dimerization is probably
not important for helicase activity (17).
Little is known about the role of interactions between HCV proteins in
viral replication. We identified viral protein-protein interacting
partners using the yeast two-hybrid system and found that NS3 interacts
strongly with itself. A fragment of 174 amino acids near the N terminus
of the helicase region was defined to be the minimal region necessary
for interaction of the region with NS3 and with itself. Under the
conditions used for gel filtration, we showed that the presence of a
single-stranded oligonucleotide is absolutely required for
dimerization. Higher oligomers were not detected. To test the
hypothesis that the activity of the HCV helicase is dependent on dimer
formation, we generated mutants that showed little or no interaction
with another helicase molecule. A reduction in dimerization is
correlated with a decrease in helicase activities in three mutants
tested. The residues that are involved in dimerization were thus
identified, and this could provide useful information for designing
compounds that inhibit protein-protein interaction at these positions.
Construction of plasmids.
cDNA clones encoding NS3 were
prepared from HCV-infected serum by reverse transcription-PCR (S. P. Lim et al., unpublished results). For the yeast two-hybrid
interaction assays (4), NS3 clones were fused in frame
with the Gal4 DNA binding domain (BD) and the Gal4 activating domain in
pAS2-1 and pACT2 vectors (Clontech), respectively. Truncations of NS3
are summarized in Table 1 and Fig.
1A. For
protein expression, DNA fragments were cloned in frame with the
glutathione S-transferase (GST) coding region in a modified
pGEX-2TK plasmid (Pharmacia). Proteins were tagged with Flag or myc in
pXJ40 (28) for expression in mammalian cells (Table 1).
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.205-214.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mutations That Affect Dimer Formation and Helicase
Activity of the Hepatitis C Virus Helicase
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
the core (C), two envelope proteins (E1 and
E2), and p7, a small peptide of unknown function
are released by host
peptidases. The nonstructural proteins NS2, NS3, NS4A, NS4B, NS5A, and
NS5B are proteolytic products of NS3, which has a trypsin-like
protease domain in the N-terminal one-third of the protein. The
assembly of a complex of C with the viral RNA, as well as with
E1 and E2, has been described, and this assembly is presumably
important for packaging of viral particles. Interaction among the
nonstructural proteins has also been shown (18, 22). NS4A
acts as an activating cofactor for NS3, and its binding to NS3
modulates the protease activity for NS3-NS4A, NS4A-NS4B, and NS5A-NS5B cleavage sites (14). NS4A binding also
serves to uncouple the helicase and
ATPase-single-stranded-RNA binding activities of NS3
(7). NS5B, the RNA-dependent RNA polymerase, interacts with NS3 (10), which has a helicase domain in the
C-terminal two-thirds of the protein, and this association is probably
important for the replication of the viral RNA. NS4A, NS4B, and NS5A
have been found to form a complex (16). These data show
that nonstructural viral proteins form complexes with one
another and possibly also recruit cellular proteins for some
process(es) in viral replication and maturation. Long-term
sequestration of host proteins for viral functions may indirectly lead
to pathogenesis of the liver.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Plasmids used in this
study


View larger version (68K):
[in a new window]
FIG. 1.
(A) A minimal domain of NS3 required for interaction was
defined using the yeast two-hybrid assay. N- and C-terminal truncations
in NS3 were made, and the fragments were cloned into pAS2-1. These
were transformed into PJ69-2A, and transformants were mated with Y187
carrying pACT-NS3. The resulting diploids were patched onto
Trp
Leu plates, replica plated onto
His and
Ade plates, and
also lifted onto a nylon membrane for the
-Gal assay. A fragment
encompassing aa 182 to 335 near the N terminus of the helicase domain,
which includes conserved residues important for NTP-binding, NTPase,
and helicase activities, was defined to be the minimal region required
for interaction with NS3. Positive interactions were indicated by
growth on
His and
Ade plates and by the presence of
-Gal
activity. (B) IP between Flag-NS3 and myc-tagged NS3 proteins. COS
cells were transfected with Flag-NS3 and myc-NS3 or with myc-NS3 alone.
Total protein (100 µg) from transfected cells was used for IP using
an anti-Flag agarose gel. Lane 1, myc-NS3 was detected in the complex
precipitated with an anti-Flag gel, demonstrating interaction
between myc-NS3 and Flag-NS3. Lane 2, myc-NS3 was not precipitated by
the anti-Flag gel in the absence of Flag-NS3, showing the specificity
of the anti-Flag gel used for IP. Lanes 3 and 4, 1/10 of the input IP
proteins was probed with anti-Flag antibody to show that Flag-NS3 was
specifically precipitated by the anti-Flag gel. Lanes 5 through 7, Western blot of total cell lysate (20 µg loaded) to detect the
expression of each of the tagged NS3 proteins in transfected cells.
IgG, immunoglobulin G.
Manipulation of yeasts and yeast two-hybrid assays.
Manipulation of yeasts for two-hybrid assays was done as described in
the Matchmaker user's manual (Clontech). In this system, the presence
of an interaction between two viral proteins was indicated by the
activation of the reporter genes HIS3 and ADE2, which allow for growth on
His and
Ade media, respectively,
and LacZ, a
-galactosidase (
-Gal) that produces a blue color when the substrate X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) (Sigma) is cleaved. The activation of these three reporters indicates the strength of the interactions, with LacZ+ and
Ade+ phenotypes indicating stronger interaction
than the His+ phenotype. The pAS2-1 and pACT2
constructs were transformed into PJ69-2A (MATa
trp1-901 leu2-3,112 ura3-52 his3-200 ade2-101 gal4
gal80
LYS2::GALUAS-GAL1TATA-HIS3
GAL2UAS-GAL2TATA-ADE2) and Y187
(MAT
trp1-901 leu2-3,112 ura3-52 his3-200 ade2-101 gal4
gal80
met
URA3::GALUAS-GAL1TATA-LACZ),
respectively. To test for interaction, the two strains carrying various
fragments of NS3 were mated on yeast extract-peptone-dextrose
(YEPD) plates and then transferred onto
Trp
Leu plates to select
for diploids that have both plasmids. They were then replica plated
onto
Trp
Leu
His and
Trp
Leu
Ade plates and also assayed
for
-Gal activity. We confirmed the interactions by retransforming
the pairs of constructs into the haploid strains PJ69-2A and Y187 and
assaying for the activation of the appropriate reporter genes.
-Gal activity assay is done by lifting patches of cells
from a plate onto a nylon membrane (Hybond N; Amersham), placing the
membrane, with the cells facing up, on a fresh plate to allow the
patches of cells to grow for a day, and then performing a "blue"
assay on the membrane. The membrane was dipped in liquid nitrogen for a
few seconds and then transferred (cells facing up) onto a piece of
filter paper (3M) soaked in 1.8 ml of Z buffer (60 mM
Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM
MgSO4) and 25 µl of X-Gal (25 mg/ml dissolved
in dimethylformamide). Membranes were incubated at 30°C to allow the
blue color to develop (up to a few hours).
Generation of mutations in NS3 helicase.
A two-step PCR was
used to generate site-directed mutations (9). Random
mutations in the minimal region were generated by lowering the
nucleotide ratio of each of the four nucleotides to 1:4:4:4 (final
concentrations are 25 µM:100 µM) in four separate PCRs using BD
forward and BD reverse primers (see Fig. 4A) on template pFG150
(pAS-min). The products of the four reactions were pooled, and the
resulting product was cotransformed with a gapped plasmid containing a
deletion in the minimal region into PJ69-2A (pFG166 cut with
EagI). Plasmids become repaired in yeast to generate a
circular plasmid (24). This pool of transformed cells was
mated overnight with a Y187 strain containing pACT-min in YEPD liquid
medium. An aliquot of mated cells was plated on
Trp
Leu medium,
while the rest were kept at 4°C. This gives an estimate of the amount
of cells to be plated to give an appropriate density for screening
(about 500 to 700 per plate). After about 2 days, the remaining cells
were diluted accordingly and then plated on
Trp
Leu plates and
incubated at 30°C until colonies appeared. The colonies were replica
plated onto
His
Trp
Leu plates to identify colonies that could
not grow on
His medium, indicating a lack of interaction. Plasmids
from these mutants were extracted and transformed into bacteria. To
quickly check that they contained a properly repaired plasmid, PCR was
done directly on the bacterial cells with BD forward and BD reverse primers. Those that contained an insert were amplified and
retransformed into PJ69-2A carrying pACT-min and tested for
interaction on
His
Trp
Leu medium.
Protein expression and purification and analytical gel
filtration.
To express the helicase in bacteria, the helicase
region (aa 182 to 680) was cloned into a derivative of the bacterial
expression vector pGEX-2TK (Pharmacia) and transformed into BL21
(Stratagene). The GST-helicase fusion protein expression was induced in
the presence of 1 mM
isopropyl-1-thio-
-D-galactopyranoside (IPTG) and
cultured for 3 h at 37°C. For the dimerization mutants, protein expression was induced at 18°C overnight with 0.5 mM IPTG, and cells
were harvested and sonicated once in lysis buffer and a second time in
300 mM NaCl in lysis buffer. These conditions appear to increase the
yield and solubility of the mutant proteins. The cells from 1 liter of
culture were harvested and disrupted with a Microson ultrasonic
homogenizer (model XL2000) in 10 pellet volumes of lysis buffer (50 mM
Tris-HCl [pH 7.6], 1 mM
-mercaptoethanol, 1 mM EDTA, 1% Triton
X-100, 100 mM NaCl, 5% glycerol). The insoluble materials were
pelleted at 18,000 rpm for 45 min in a Sorvall SS34 rotor, and 500 µl
of glutathione Sepharose beads (Pharmacia) was added to the clarified
supernatant. The beads were allowed to bind for 2 h, and then they
were washed four times in lysis buffer and four times in cleavage
buffer (50 mM Tris [pH 8], 150 mM NaCl, 0.1%
-mercaptoethanol,
2.5 mM CaCl2, and 1 mM dithiothreitol). The
helicase was cleaved from the GST moiety with thrombin (10 U/liter of
culture; Sigma) for 45 min. All steps were performed at 4°C unless
otherwise stated.
Helicase activity assay.
A double-stranded
oligodeoxynucleotide was used as a substrate for helicase activity
assays, since NS3 helicase was shown to be about as effective in
unwinding DNA as RNA duplexes (26). The substrate was made
by annealing the high-pressure liquid chromatography-purified oligonucleotides OLG54
(5'GTCAGTTGAGTGGCAGGCGGCACACATTATAGTGTCGTAGGCTTC3') and
OLG55 (GTGTGCCGCCTGCCACTCAACTGACTCAACTACTGTCTTGGGCATCGGCA) (Genset Inc.), which when annealed give a 25-bp 3' overhang at both
ends. OLG54 was end labeled with polynucleotide kinase (New England
Biolabs) using [
-32P]ATP and purified using
a nucleotide purification kit (Qiagen). The two overlapping
single-stranded DNAs were mixed with a molar excess of the unlabeled
oligonucleotide and annealed by cooling the mixture from 75°C to room
temperature gradually. Each reaction contained 20 nM substrate and 400 nM helicase in binding buffer made up to a total of 10 µl in reaction
buffer (20 mM HEPES-KOH [pH 7.0], 2 mM dithiothreitol, 1.5 mM
MnCl2, 2.5 mM ATP, 0.1 mg of bovine serum albumin
per ml). The reactions were terminated by adding 6× DNA gel loading
dye, and products were run on 10% acrylamide gels (29:1, acryl-bis) in
0.5× Tris-borate-EDTA buffer. The gel was dried, and radioactivity in
the single- and double-stranded DNA and protein-bound DNA was detected
on an autoradiograph or quantitated on a PhosphorImager (Molecular
Dynamics). The percent single-stranded, or unwound, DNA was calculated
as the percentage of the total radioactivity that was present in the
unwound DNA in each reaction mixture.
Immunoprecipitation (IP). COS cells were transfected with 2 to 4 µg of DNA using Superfect (Qiagen) according to the supplier's instructions. Twenty-four hours after transfection, cells were washed once in phosphate-buffered saline (PBS) and harvested in lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris [pH 7.4], 1 mM EDTA, 1 mM EGTA, 0.5% NP-40), with protease inhibitors added before use (0.4 mM Na3VO4, 0.4 mM phenylmethylsulfonyl fluoride), at 4°C. Total cell lysate (0.1 mg) was incubated (with rolling) with 20 µl of packed anti-Flag agarose gel (Sigma) overnight at 4°C. The gel was washed five times, each time with 1 ml of lysis buffer, and the proteins bound to the gel were extracted by boiling for 2 min in 2× sample buffer and separated by SDS-PAGE.
Western blot analysis. To analyze proteins from co-IP experiments and protein expression in transfected cells, protein samples were resolved by SDS-PAGE, transblotted onto Hybond-C membranes (Amersham), and then probed with anti-Flag monoclonal (1:1,000 dilution; Sigma) or anti-myc polyclonal (1:500 dilution; Santa Cruz Biochemicals) antibodies overnight at 4°C or at least 1 h at room temperature. After extensive washes, a secondary antibody conjugated to horseradish peroxidase (1:2,000 dilution; Pierce) was applied to the blots for at least 1 h at room temperature. Washes were done three times for 5 min each in 0.05% Tween 20 in PBS and another three times in PBS. Antibodies were diluted in 3% skimmed milk in PBS. Blots were washed, and reagents for enhanced chemiluminescence (Pierce) were added for 5 min before signal was detected on X-ray film (Hyperfilm).
| |
RESULTS |
|---|
|
|
|---|
NS3-NS3 interaction. We tested protein-protein interaction among all HCV proteins and found that NS3 interacts strongly with itself (Fig. 1A). This interaction was confirmed by coexpressing myc-tagged and Flag-tagged NS3 in COS cells and showing their association by co-IP experiments (Fig. 1B). To delineate the region(s) of NS3 important for interaction with itself, N-terminal and C-terminal deletions of NS3 were constructed in frame with the DNA-binding domain in pAS2-1. These deletions were tested for interaction with a full-length NS3 in the yeast two-hybrid assay (Fig. 1A). The C-terminal region from aa 336 to 680 containing the RNA-binding motif is apparently not required for NS3-NS3 interaction in this assay. The minimal region delineated for interaction is from aa 182 to 335, which includes motifs essential for NTP-binding, NTPase, and helicase activities. Although the minimal region we have defined is sufficient for interaction, other parts of the NS3 protein may also contribute to the stability of the NS3-NS3 interaction. Deletion of the protease domain and the C-terminal half of the NS3 protein containing the RNA-binding motif reduces the strength of the interaction. Since the protease region (aa 1 to 181) is not required for interaction, we focused our studies on the helicase region.
To determine if the interaction occurs in a head-to-head or head-to-tail orientation, we tested for interaction between the N- and C-terminal regions of the helicase using the yeast two-hybrid assay (Fig. 2A). The results show that the minimal region interacts with itself and does not interact with the C-terminal portion containing the RNA-binding region. This interaction between the minimal regions was confirmed by co-IP in mammalian cells (Fig. 2B). However, under gel filtration conditions, the N-terminal minimal region did not bind to a helicase or to itself (data not shown), suggesting that these conditions were not conducive to such interactions and that additional factors in cells or the cellular environment may be required for the minimal region to bind to NS3 and to itself.
|
|
Mutations that disrupt dimerization.
Whether the HCV helicase
functions as a monomer or a dimer has been in contention for a while.
We sought to answer this question by generating mutations that disrupt
the interaction between the helicase molecules and to correlate the
lack of interaction with the presence or absence of helicase activity
of these mutants. To generate random mutants that disrupt the
interaction between the minimal interacting domains, the minimal region
was amplified under low-fidelity conditions and cotransformed with a
gapped plasmid into PJ69-2A (see Materials and Methods) (Fig.
4A). The two fragments were repaired in yeast cells, and colonies were selected
and screened for mutants that showed no growth on
His plates. About
500 clones were screened, and 13 His
mutants
with mutations that disrupted interaction between a mutant and a
wild-type minimal region were isolated. The mutated regions from these
mutants were sequenced, and the positions of the mutations found are
shown in Fig. 5. The mutations
appear to cluster around a few pockets, around aa 200, 268, 290, and
311. These may define the residues that form noncovalent bonds with
another helicase.
|
|
His medium even upon weak activation. These mutants
showed weaker interaction than the wild-type helicase, which activates
all three reporters (Fig. 5). Therefore, single mutations in the
helicase context are not sufficient to abolish interaction completely,
and additional points of contact outside the minimal region compensate
for the binding in vivo. The S268P mutation abolished interaction
completely, but the change generated a proline, which is generally
disruptive to a protein structure.
To confirm that the mutants show weak interaction with themselves, we
expressed three mutants, T266A, Y267S, and M288T, in bacteria and
prepared the protein for gel filtration. Using the LOOK program, we
chose these mutations for biochemical studies because they were
predicted to be within beta-sheets and are less likely to cause major
disruption to the structure of the helicase. These mutations show
little or no dimerization in the presence of a single-stranded
oligonucleotide (Fig. 4B).
Correlation between dimer formation and helicase activity.
The
wild-type helicase and dimerization mutants (T266A, Y267S, and M288T)
were assayed for their helicase activities in an in vitro assay
(26) using double-stranded DNA oligonucleotides as a
substrate. Wild-type helicase unwound the substrate within 30 s,
while all the dimerization mutants unwound the substrate at a reduced
rate (Fig. 6A). To show
a more dramatic difference in helicase activity between the wild type
and the dimerization mutants, the substrate-to-enzyme ratio was
increased. Under these conditions, the wild-type helicase was very
effective in releasing single-stranded oligonucleotide, while mutants
T266A and Y267S were relatively inactive (Fig. 6A). The M288T mutant
showed a lower initial rate of unwinding but eventually unwound up to
45% of double-stranded DNA. As a negative control, the AAA mutant, which has no helicase activity, was also included. We have therefore identified mutations that abolish the dimer formation and also affect
the activities of the HCV helicase to various degrees, indicating that
helicase activity is dependent on dimerization.
|
| |
DISCUSSION |
|---|
|
|
|---|
We describe the characterization of NS3 homodimerization using a combination of yeast molecular genetic and biochemical techniques. NS3 dimerizes through the N-terminal region of the helicase domain, and several random mutations generated were able to disrupt the interaction between two helicase molecules. This lower affinity correlates with a loss of helicase activity, indicating the importance of dimerization for helicase activity.
The existence and significance of an NS3 helicase dimer have been in contention for a while. From structural (29), mutational (17), and equilibrium and velocity sedimentation centrifugation (25) experiments, the HCV helicase appears to function as a monomer, while others report that it functions as an oligomer (5). This discrepancy may be due to the relative processivity of the various forms of helicase, with monomers and oligomers having different efficiencies in unwinding activity: higher oligomers are more efficient than monomers. DNA helicases have been reported to function as monomers (23) or as oligomers (2). We showed here that the NS3 helicase interacts strongly with itself both in the yeast two-hybrid assay and in co-IP experiments. Gel filtration experiments also demonstrated that the helicase exists as a dimer in solution, and only in the presence of a single-stranded oligonucleotide. The dependence of dimerization on the binding of a single-stranded DNA is reminiscent of the Escherichia coli Rep helicase (27). Others have shown that the HCV helicase forms oligomers up to octamers in cross-linking studies (15). Under gel filtration conditions, we were able to detect only dimers and no higher oligomers. The conditions that we used may not allow for stable formation of higher oligomers, although the buffer we used for gel filtration is similar to those used in cross-linking experiments in which the HCV helicase was shown to form oligomers.
A dimer model for the NS3 helicase has been proposed based on the crystal structure of the NS3 helicase of HCV genotype 1b (5). Those authors suggested a head-to-tail orientation, where the NTPase domain appears to contact the RNA-binding domain. We, however, showed that the interaction between the helicase molecules could occur in a head-to-head orientation through the N terminus of the helicase domain in a yeast two-hybrid test as well as in co-IP experiments. This minimal region is not able to bind to itself under gel filtration conditions, indicating that these conditions may not mimic physiological conditions and/or that additional factors are needed to stimulate the dimerization of the minimal region. From our gel filtration assays, the binding of a single-stranded oligonucleotide plays an important part in inducing dimer formation.
As the helicase shows strong self-association, we wondered if it is important for optimal helicase activity. The minimal region cannot bind to the helicase under gel filtration conditions, presumably because mutual binding of a single-stranded DNA or RNA is necessary for stable dimer formation. We were therefore not able to use the minimal region to inhibit dimerization of the full-length helicase to assay its effect on the helicase activity in an in vitro assay.
To test the hypothesis that dimerization is important for helicase activity, we isolated mutants that disrupted the interaction and used these mutants to assay for helicase activities. One caveat in testing this hypothesis exists: these mutations may disrupt the structure of the helicase, so that both dimerization and helicase activity are affected. We chose mutations (T266A, Y267S, and M288T) that are less likely to perturb the structure of the helicase to assay dimerization and helicase activities. The reduction in helicase activity of the three mutants is not due to their inability to bind the substrate, since all three mutants shifted the substrate to a higher-molecular-weight form (Fig. 6 and our unpublished data). The reduction in helicase activities compared to that of the wild type could therefore be attributed to a reduction in dimer formation, suggesting that dimerization contributes to a more efficient unwinding activity of the NS3 helicase. This conclusion was also confirmed by the reduction of activity of wild-type helicase by the addition of mutant AAA and by a less significant decrease by the addition of a dimerization mutant, Y267S.
The requirement of dimerization of the NS3 protein for optimal helicase activity has interesting implications for HCV replication in an infected cell. Translation of the positive-strand RNA genome and processing of the polypeptide produces a single molecule of NS3. If helicase activity is absolutely dependent on the dimerization of NS3, then multiple rounds of translation must be completed before active NS3 dimers are formed to facilitate RNA replication. The requirement for dimerization may limit the rate of RNA replication and may explain the low rate of replication in the early phase of infection. However, we believe that monomeric NS3 possesses some helicase activity, since two of the dimerization mutants (T266A and M288T) tested showed little dimerization but were able to unwind duplex DNA to some extent (Fig. 4B and 5).
The effect of mutations that disrupt dimerization on the replication of the HCV awaits testing in a cell culture system that expresses the viral genome containing these mutations. The definition of critical residues involved in protein-protein contact could potentially provide useful information for designing compounds that specifically inhibit the dimerization. Such inhibitors will be specific to this helicase, as the dimer structure of the HCV helicase is unique.
| |
ACKNOWLEDGMENTS |
|---|
We thank A. Tay and her lab members for sequencing DNA clones, A. Ting, Y. J. Tan, and P. Kolatkar for advice, and J. Goh and A. Low for technical assistance.
This work was supported by grants from the National Science and Technology Board, Singapore.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Collaborative Anti-Viral Research Group, Institute of Molecular and Cell Biology, 30 Medical Dr., Singapore 117609, Singapore. Phone: (65) 874 3387 or 874 7820. Fax: (65) 779 1117. E-mail: mcbgohpy{at}imcb.nus.edu.sg.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ali, J. A., N. K. Maluf, and T. M. Lohman. 1999. An oligomeric form of E. coli UvrD is required for optimal helicase activity. J. Mol. Biol. 293:815-834[CrossRef][Medline]. |
| 2. |
Bujalowski, W.,
M. M. Klonowska, and M. J. Jezewska.
1994.
Oligomeric structure of Escherichia coli primary replicative helicase DnaB protein.
J. Biol. Chem.
269:31350-31358 |
| 3. | Chao, K. L., and T. M. Lohman. 1991. DNA-induced dimerization of the Escherichia coli Rep helicase. J. Mol. Biol. 221:1165-1181[Medline]. |
| 4. |
Chien, C. T.,
P. L. Bartel,
R. Sternglanz, and S. Fields.
1991.
The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest.
Proc. Natl. Acad. Sci. USA
88:9578-9582 |
| 5. |
Cho, H.-S.,
N.-C. Ha,
L.-W. Kang,
K. M. Chung,
S. H. Back,
S. K. Jang, and B.-H. Oh.
1998.
Crystal structure of RNA helicase from genotype 1b hepatitis C virus.
J. Biol. Chem.
273:15045-15052 |
| 6. |
Choo, Q. L.,
G. Kuo,
A. J. Weiner,
L. R. Overby,
D. W. Bradley, and M. Houghton.
1989.
Isolation of cDNA clone derived from a blood-borne non-A, non-B hepatitis genome.
Science
244:359-362 |
| 7. | Gallinari, P., C. Paolini, D. Brennan, C. Nardi, C. Steinkuhler, and R. de Francesco. 1999. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A. Biochemistry 38:5620-5632[CrossRef][Medline]. |
| 8. | Heilek, G. M., and M. G. Peterson. 1997. A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J. Virol. 71:6264-6266[Abstract]. |
| 9. | Higuchi, R. 1989. Using PCR to engineer DNA, p. 61-70. In H. A. Erlich (ed.), PCR technology. Stockton Press, New York, N.Y. |
| 10. | Ishido, S., T. Fujita, and H. Hotta. 1998. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244:35-40[CrossRef][Medline]. |
| 11. | Kim, D. W., J. Kim, Y. Gwack, J. H. Han, and J. Choe. 1997. Mutational analysis of the hepatitis C virus RNA helicase. J. Virol. 71:9400-9409[Abstract]. |
| 12. | Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355[CrossRef][Medline]. |
| 13. | Kim, J. L., K. A. Morgenstern, J. P. Griffith, M. D. Dwyer, J. A. Thomson, M. A. Murcko, C. Lin, and P. R. Caron. 1998. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6:89-100[Medline]. |
| 14. | Koch, J. O., V. Lohmann, U. Herian, and R. Bartenschlager. 1996. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. Virology 221:54-66[CrossRef][Medline]. |
| 15. |
Levin, M. K., and S. S. Patel.
1999.
The helicase from hepatitis C virus is active as an oligomer.
J. Biol. Chem.
274:31839-31846 |
| 16. | Lin, C., J. W. Wu, K. Hsiao, and M. S. Su. 1997. The hepatitis C virus NS4A protein: interactions with NS4B and NS5A proteins. J. Virol. 71:6465-6471[Abstract]. |
| 17. |
Lin, C., and J. L. Kim.
1999.
Structure-based mutagenesis study of hepatitis C virus NS3 helicase.
J. Virol.
73:8798-8807 |
| 18. |
Lo, S. Y.,
M. J. Selby, and J. H. Ou.
1996.
Interaction between hepatitis C virus core protein and E1 envelope protein.
J. Virol.
70:5177-5182 |
| 19. | Love, R. A., H. E. Parge, J. A. Wickersham, Z. Hostomsky, N. Habuka, E. W. Moomaw, T. Adachi, and Z. Hostomska. 1996. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87:331-342[CrossRef][Medline]. |
| 20. | Major, M. E., and S. M. Feinstone. 1997. The molecular virology of hepatitis C. Hepatology 25:1527-1538[CrossRef][Medline]. |
| 21. |
Manser, E.,
H. Y. Huang,
T. H. Loo,
X. Q. Chen,
J. M. Dong,
T. Leung, and L. Lim.
1997.
Expression of constitutively active -PAK reveals effects of the kinase on actin and focal complexes.
Mol. Cell. Biol.
17:1129-1143[Abstract].
|
| 22. | Matsuura, Y., T. Suzuki, R. Suzuki, M. Sato, H. Aizaki, I. Saito, and T. Miyamura. 1994. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205:141-150[CrossRef][Medline]. |
| 23. |
Mechanic, L. E.,
M. C. Hall, and S. W. Matson.
1999.
Escherichia coli DNA helicase II is active as a monomer.
J. Biol. Chem.
274:12488-12498 |
| 24. | Mulrad, D., R. Hunter, and R. Parker. 1992. A rapid method for localised mutagenesis of yeast genes. Yeast 8:79-82[CrossRef][Medline]. |
| 25. |
Porter, D. J. T.,
S. A. Short,
M. H. Hanlon,
F. Preugschat,
J. E. Wilson,
D. H. Willard, Jr., and T. G. Consler.
1998.
Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.
J. Biol. Chem.
273:18906-18914 |
| 26. | Tai, C.-L., W.-K. Chi, D.-S. Chen, and L.-H. Hwang. 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 70:8477-8484[Abstract]. |
| 27. |
Wong, I.,
K. L. Chao,
W. Bujalowski, and T. M. Lohman.
1992.
DNA-induced dimerization of the Escherichia coli Rep helicase.
J. Biol. Chem.
267:7596-7610 |
| 28. | Xiao, J. H., I. Davidson, H. Matthes, J. M. Garnier, and P. Chambon. 1991. Cloning, expression and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551-568[CrossRef][Medline]. |
| 29. | Yao, N., T. Hesson, M. Cable, Z. Hong, A. D. Kwong, H. V. Le, and P. C. Weber. 1997. Structure of the hepatitis C virus RNA helicase domain. Nat. Struct. Biol. 4:463-467[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»